Launch of 온라인 바카라 cosmetics utilizing inflammatory complex inhibitor technology
[by Ji, Yong Jun] Shaperon announced on July 21 its plans to introduce a line of healthcare cosmetics aimed at the ‘inflammaging’ market, leveraging its proprietary inflammatory complex inhibitor technology. To this end, the company has registered a key active ingredient in the ‘International Cosmetic Ingredients Dictionary and Handbook (ICID)’ and the corresponding domestic database and is currently in the process of registering four additional ingredients.
The company states that the raw material represents the culmination of Shaperon’s proprietary platform technology and clinical trial expertise developed over the past 10 years of new drug development. It is anticipated to exert effects in regulating inflammatory responses and mitigating signs of aging. Based on this material, Shaperon intends to release three healthcare products within the year.
Contemporary skin is increasingly subjected to various environmental stressors, including ultraviolet radiation, fine dust, and psychological stress, which contribute to the acceleration of aging through the persistence of micro-inflammation. The concept of ‘inflammaging,’ which has recently garnered global attention, refers to a novel approach aimed at suppressing chronic micro-inflammation states to improve skin health and decelerate the aging process.
The company particularly noted that factors such as the rise in outdoor activities, worsening air pollution, and shifts in dietary habits have led to an increase in micro-inflammation in the skin’s sweat and sebaceous glands, identified as key contributors to wrinkle formation and skin aging. Therefore, there is a growing demand for functional products capable of addressing these inflammatory processes.
In response to these evolving market changes, 온라인 바카라 has been developing healthcare products designed to alleviate skin concerns and improve micro-articular inflammation, utilizing various compounds identified during its new drug development efforts. The company further stated that these products are expected to reduce everyday discomfort and serve as a viable solution for promoting a more active and vibrant lifestyle.
Since the COVID-19 pandemic, interest in maintaining a healthy lifestyle has grown significantly, leading to increased demand for products that alleviate micro-inflammation and muscle-joint discomfort following physical activity. However, product offerings in this segment remain limited, particularly those supported by scientific evidence. In response, 온라인 바카라 plans to introduce a healthcare product that leverages its proprietary technology to address discomfort associated with exercise-induced micro-damage and inflammation.
“We are currently in the final stages of finalizing the brand concept and container design, with plans to launch the product to the market within the year,” a company official said. “To ensure that this business evolves into a stable cash-generating pillar supporting the company, we intend to establish a dedicated team, recruit external experts, and implement a management system based on a virtuous financial cycle.”